According to the latest research by Future Market Insights, the Pancreatic Elastase Testing Market will undergo a steady growth during 2021-2031. A gradual increase due to constant research studies being conducted and new verticals of disease treatment being opening can be seen over the mentioned forecast period. The increasing innovations and advancements in developing new therapeutic techniques and products will further boost the market.
What is Driving Demand for Pancreatic Elastase Testing Market?
Pancreatic elastase is a type of enzyme secreted by the pancreas. This enzyme breaks down fats, proteins, carbohydrates, etc. as it plays a crucial role in the digestion process.
Changes in level of pancreatic elastase helps in determining whether the pancreas are functioning in a proper manner or not. Decrease in its level indicates towards insufficiency of the pancreas.
The prominent drivers in this market are the rising levels of fat in individuals due to sedentary lifestyle and increased alcoholism most probably due increase in competition among individuals which can lead to severe stress levels.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14047
A study was published in Oxford Academic in 2016 which ventured into analysing the relationship between pancreatic elastase and diabetes mellitus. The researchers used ELISA for determining PE levels in the patients with diabetes mellitus. They concluded that, there exists a strong association between the changes in PE levels and diabetes mellitus.
Individuals affected with diabetes mellitus showed a significant decrease in amount of PE. This discovery can potentially be used to detect diabetes in suspected individuals with the help of early testing so that proper management of the disease can be done.
Diagnostic and therapeutic approach towards pancreatic insufficiency
Pancreatic insufficiency can be caused due to various types of pancreatic diseases like chronic pancreatitis, acute pancreatitis. Pancreatitis causes about 86,000 hospital admissions per year in United States. This makes it even more important to explore different and new approaches towards its management.
A study was published in Wiley Online Library which aimed to find out if a more therapeutic and diagnostic approach could be taken in treating a pancreatic insuffiency post pancreatitis. According to their findings, early diagnosis has many merits here as it prevents future complications in malabsorption of nutrition and leads to an adequate as well as timely treatment. This can be achieved with proper and timely testing of PE.
They further summarized that proper improvements in the diet will lead to maintaining of a nutritional status as per the normal values, but also avoid any complications associated with malabsorption of these nutrients.
U.S. and Canada Pancreatic Elastase Testing Market –
According to data given by American Addiction Centres, 95,000 American dies every year i.e. 261 per day die due to alcohol-related complications. Alcohol plays a major role in causing pancreatitis, which ultimately leads to pancreatic insufficiency.
This is what makes US the second most lucrative market is that of North American region. The main contributing factor behind the steady growth of this market is the availability of advanced facilities at healthcare centres.
Europe Pancreatic Elastase Testing Market –
Europe leading the pancreatic elastase testing market can be credited to continuous encouragement for the researchers in doing research and inventions related to various healthcare verticals.
For instance, ScheBo Biotech AG from Germany, inventors there created a test kit in 2021 consisting of a pancreatic elastase 1-specific antibody along with a device for sample collection and a proprietary extraction buffer. It can detect levels of elastase in faeces at a much higher accuracy than the present kits.
Who are the key manufacturing and supplying companies in Pancreatic Elastase Testing Market?
Key players:
- Novozymes
- DuPont
- AB Enzymes
- DSM
- Aum Enzymes
- BASF
- Buhlmann Diagnostics Corp
- Bioserv Diagnostics
- CHR Hansen
- Kemin
- avail
For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14047
Why Future Market Insights?
- Comprehensive analysis on evolving purchase pattern across different geographies
- Detailed insights of market segments and sub-segments for historical as well as forecast period
- A competitive analysis of prominent players and emerging players in the keyword market
- Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com